Rapport Therapeutics, Inc. (RAPP)
39.50
+0.01
(+0.03%)
USD |
NASDAQ |
May 29, 16:00
39.44
-0.06
(-0.15%)
After-Hours: 20:00
Rapport Therapeutics EPS Diluted (Quarterly) : -0.4204 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| EyePoint, Inc. | -0.9864 |
| Biofrontera, Inc. | -0.4067 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.86M |
| Revenue (Quarterly) | 20.00M |
| Total Expenses (Quarterly) | 39.86M |
| Enterprise Value | 1.423B |
| Gross Profit Margin (Quarterly) | 98.86% |
| Profit Margin (Quarterly) | -99.28% |
| Earnings Yield | -6.59% |
| Normalized Earnings Yield | -6.590 |